Summary
The apolipoprotein E4 allele (APOEɛ4) and atherosclerosis are risk factors for cognitive decline. We investigated whether the effects of APOEɛ4 and atherosclerosis on cognitive decline are independent. A population-based follow-up study was performed on 838 subjects who were non-demented at baseline. The Mini Mental State Examination (MMSE) score at follow-up was studied as a function of APOEɛ4 and atherosclerosis. Mild, non-significant effects on the MMSE score were found for atherosclerosis in the absence of APOEɛ4 and for APOEɛ4 in the absence of atherosclerosis. APOEɛ4 carriers with two or more indicators of atherosclerosis positive, had a significantly lower MMSE score at follow-up (mean difference −0.7 points; 95% confidence interval −1.1 to −0.2) relative to non-APOEɛ4 carriers with no evidence of atherosclerosis. Our findings suggest that the consequences of APOEɛ4 and atherosclerosis are not independent, and that particularly APOEɛ4 carriers with atherosclerosis are at increased risk of cognitive decline.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alberts MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter WJ, Saunders AM, Roses AD (1995) ApoE genotype and survival from intracerebral haemorrhage. Lancet 346: 575
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd rev ed. DSM-III-R. American Psychiatric Association, Washington DC
Bots ML, Van Switen JC, Breteler MMB, De Jong PTVM, Van Gijn J, Hofman A, Grobbee DE (1993) Common carotid artery cerebral white matter lesions and atherosclerosis in the Rotterdam study. Lancet 341: 1232–1237
Bots ML, Hofman A, De Jong PTVM, Grobbee DE (1996) Common carotid artery intima-media thickness as an indicator of atherosclerosis at other sides of the carotid artery: the Rotterdam study. Ann Epidemiol 6: 147–153
Breteler MMB, Claus JJ, Grobbee DE, Hofman A (1994) Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study. BMJ 308: 1604–1608
Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 7: 180–184
Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1–21
Folstein MS, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198
Fowkes FGR, Housley E, Cawood EHH, Macintyre CCA, Ruckley CV, Prescott RJ (1991) Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20: 384–392
Grobbee DE, Bots ML (1994) Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J Int Med 236: 567–573
Henderson AS, Easteal S, Jorm AF, Mackinnon AJ, Korten AE, Christensen H, Croft L, Jacomb PA (1995) Apolipoprotein E allele ∈4, dementia, and cognitive decline in a population sample. Lancet 346: 1387–1390
Hofman A, Grobbee DE, De Jong PTVM, Van den Ouweland FA (1991) Determinants of disease and disability in the elderly: the Rotterdam elderly study. Eur J Epidemiol 7: 403–422
Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, Van Harskamp F, Van Duijn CM, Van Broeckhoven C, Grobbee DE (1997) Atherosclerosis, apolipoprotein E, and the prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet 349: 151–154
Hyman BT, Gomez-Isla T, Briggs M, Chung H, Nichols S, Kohout F, Wallace R (1996) Apolipoprotein E and cognitive change in an elderly population. Ann Neurol 40: 55–60
Kida E, Pluta R, Lossinsky AS, Golabek AA, Choi-Miura N-H, Wisniewski HM, Mossakowski MJ (1995) Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the brain. Brain Res 674: 341–346
Kuusisto J, Koivisto K, Kervinen K, Mykkänen L, Helkala E-L, Vanhanen M, Hänninen T, Pyörälä, Kesäniemi YA, Riekkinen P, Laakso M (1994) Association of apolipoprotein E phenotypes with late onset Alzheimer’s disease: population based study. BMJ 309: 636–638
Kuusisto J, Mykkänen L, Kervinen K, Kesäniemi A, Laakso M (1995) Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly patients. Arterioscler Tromb Vasc Biol 15: 1280–1286
Mahley RW, Nathan BP, Bellosta S, Pitas RE (1995) Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimer’s disease. Curr Opin Lipidol 6: 86–91
Meyer JS, Kawamura J, Terayama Y (1992) White matter lesions in the elderly. J Neurol Sci 110: 1–7
Netherlands Central Bureau of Statistics (1987) Standard classification of education SOI-1978. Netherlands Central Bureau of Statistics, Voorburg
Ottman R (1990) An epidemiologic approach to gene-environment interaction. Genet Epidemiol 7: 177–185
Ouriel K, McDonnell AE, Metz CE, Zarins CK (1982) A critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 91: 686–693
Pedro-Botet J, Senti M, Nogués X, Rubiés-Prat J, Roquer J, D’Olhaberriague L, Olivé J (1992) Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 23: 1556–1562
Poirier J (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer’s disease. Trends Neurosci 17: 525–530
Rose G (1985) Sick individuals and sick populations. Int J Epidemiol 14: 32–38
Slooter AJC, Tang M-X, Van Duijn CM, Stern Y, Ott A, Bell K, Breteler MMB, Van Broeckhoven C, Tatemichi TK, Tycko B, Hofman A, Mayeux R (1997) Apolipoprotein E4 increases the risk of dementia with stroke. A population-based investigation. JAMA 277: 818–821
Stern Y, Brandt J, Albert M, Jacobs DM, Liu X, Bell K, Marder K, Sano M, Albert S, Del-Castillo Castenada C, Bylsma F, Tycho B, Mayeux R (1997) The absence of an apolipoprotein ∈4 allele is associated with a more aggressive form of Alzheimer’s disease. Ann Neurol 41: 615–620
Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977–1981
Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate A (1994) Protection against Alzheimer’s disease with apoE ∈2. Lancet 343: 1432–1433
Tombaugh TN, Mclntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40: 922–935
Van Bockxmeer FM, Mamotte CDS (1992) Apolipoprotein ∈4 homozygosity in young men with coronary heart disease. Lancet 340: 879–880
Van Duijn CM, De Knijff P, Wehnert A, De Voecht J, Bronzova JB, Havekes LM, Hofman A, Van Broeckhoven C (1995) The apolipoprotein E ∈2 allele is associated with an increased risk of early-onset Alzheimer’s disease and a reduced survival. Ann Neurol 37: 605–610
Van Duijn CM (1996) Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychiatry 60: 478–488
Van Swieten JC, Van den Hout JH, Van Ketel BA, Hijdra A, Wokke JH, Van Gijn J (1991) Periventricular lesions in the white matter on magnetic resonance imaging in the elderly: a morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 114: 761–774
Vogt MT, Wolfson SK, Kuller LH (1992) Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol 45: 529–542
Wenham PR, Price WH, Blundell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337: 1158–1159
Wong M, Edelstein J, Wollman J, Bond MG (1993) Ultrasonic-pathological comparison of the human arterial wall. Verification of intima-media thickness. Arterioscler Tromb 13: 482–486
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Wien
About this paper
Cite this paper
Slooter, A.J.C. et al. (1998). Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam study. In: Jellinger, K., Fazekas, F., Windisch, M. (eds) Ageing and Dementia. Journal of Neural Transmission. Supplementa, vol 53. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6467-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6467-9_3
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83114-4
Online ISBN: 978-3-7091-6467-9
eBook Packages: Springer Book Archive